University of California, Berkeley biochemist Jennifer Doudna won the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for their pioneering work on CRISPR-Cas9. This revolutionary ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Broad coalition of world's greatest thinkers make urgent plea for 'moonshot' efforts to solve 'tragic mismatch of global food <a target=_blank hr ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

Back in 2014, CRISPR and its associated Cas proteins were mostly limited to academic research, generating a lot of excitement ...

Nobel Prize Winner & ERS Genomics Co-Founder, said: "Our new express license platform represents an exciting step forward in democratizing access to the foundational CRISPR/Cas9 IP. By simplifying ...